36th Annual North Central Heart Cardiac Symposium

Friday, November 2, 2018, 8:00 AM - 5:00 PM, Sioux Falls Convention Center

Registration Fee:
$90 per participant

***AVERA EMPLOYEES: If your leader has agreed to pay your registration fees, please register yourself and answer the appropriate questions within the registration form***

Cancellation Policy:  A refund less 5% of registration fee will be given for cancellations received in writing to [email protected] prior to 5 business days of activity.  Following this date, no refunds will be given but substitutions will be accepted.

Videoconference:  This conference will not be provided via videoconference.

Upon completion of this program the learner will gather information that will highlight current evidence-based concepts and technology for the evaluation, diagnosis and management of cardiovascular patients.

1. Review the effects of obesity on CVD risk factors and CVD.
2. Discuss the impact of physical activity and fitness for protecting against CVD mortality and all-cause mortality, including the obesity paradox.
3. Explain the Fit vs Fat controversy including their relative importance regarding prognosis.
4. Explain the role of adjuvant therapy with PCSK9 inhibitors, including therapy goals.
5. Discuss management of common valvular heart conditions in women of childbearing age
6. Identify high risk valvular heart conditions during pregnancy.
7. Define the risk factors for atrial fibrillation.
8. Describe the indications for anticoagulation therapy.
9. Describe the practical approach to obtain strain images.
10. Discuss clinical application of strain imaging.
11. Differentiate the various types of wide complex tachycardia.
12. Explain how to manage WQT in emergency settings.
13. Discuss long term management of different types of WCT.
14. Discuss patient workflow within a heart failure clinic.
15. Explain guideline directed medical therapy for heart failure patients.
16. Discuss the role of cardiac testing in evaluating cardiovascular risk for non-cardiac surgical patients.
17. Describe the clinical approach to preoperative cardiac risk assessment.
18. Compare and contrast options regarding wearable cardiac defibrillator after myocardial infarction.

All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner.

 

ADA Statement:

ADA accommodations will be made in accordance with the law.  If you require ADA accommodations, please indicate what your needs are at the time of registration.  We cannot ensure the availability of appropriate accommodations without prior notification.

CME Accreditation Statement: 
Avera is accreditated by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  Avera designates this educational activity for a maximum of 6.4 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

CNE Accreditation Statement: 
Avera Health is an approved provider of continuing nursing education by the Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. A total of 6.4 contact hours can be received upon completion of this education activity. Attendance at the entire educational activity is required to receive contact hours.

ASRT: 
The American Society of Radiologic Technologists has approved this program for up to 6.0 Category A Credits. 

Pharmacy:
The South Dakota Department of Pharmacy has approved this program for 6 Contact Hours.

Friday, November 2, 2018